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After the publication of our article (Ma et  al. 2016), we 
became aware of an error in the “Fusion transcript detec-
tion and validation” section of our Results.
“Two gene fusions had been found by previous studies: 
UBE2L3-KRAS (Wang et al. 2011) expressed in all three 
cell lines and TAF15-AP2B1 (http://54.84.12.177/Pan-
CanFusV2/Fusions!fusion) specific expressed in Du145 
(Additional file 3). The other fourteen fusions were novel 
discovered.” 
Should read:
“Two gene fusions had been found in prostate can-
cer in previous studies (Wang et  al. 2011; Klijn et  al. 
2015): UBE2L3-KRAS and C14orf166-SLC25A21 were 
expressed in all three cell lines in our study (Additional 
file  3). The other fourteen fusions are reported here for 
the first time in prostate cancer.”
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